Endotis Pharma
Latest round
- Series B
Last raised
- Jan 2008
Total raised
- $41M
Investors
- 4
About Endotis Pharma
Endotis Pharma is a Paris-based company specializing in innovative pharmaceuticals.Endotis Pharma operates in the pharmaceutical sector, focusing on therapeutic innovations. The company was established in Paris, France.Endotis Pharma engages in the development of pharmaceuticals, with a focus on advanced treatment solutions for various medical conditions.Endotis Pharma's revenue model is centered around the successful development and commercialization of its pharmaceutical products.The future growth strategy for Endotis Pharma involves plans to enhance its product pipeline with new pharmaceutical offerings aimed at addressing specific health challenges.
Who invested in Endotis Pharma
4 investors across 2 rounds
See all investors in Endotis Pharma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Endotis Pharma
Who invested in Endotis Pharma?
Endotis Pharma has 4 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Endotis Pharma raised?
Endotis Pharma has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Endotis Pharma last raise money?
Endotis Pharma's most recent round on record is a Series B, in Jan 2008.
What does Endotis Pharma do?
Endotis Pharma is a Paris-based company specializing in innovative pharmaceuticals.
Where is Endotis Pharma headquartered?
Endotis Pharma is headquartered in Paris, France.
Which VCs invest in companies like Endotis Pharma?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at Endotis Pharma's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Endotis Pharma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.